STERIS whippany, new jersey facility accepted into OSHA VPP programs at star level

July 8, 2024

  • Programs promote effective worksite-based safety and health
  • Acceptance represents STERIS’s 13th facility to receive VPP Star status

STERIS Applied Sterilization Technologies is pleased to announce that the U.S. Occupational Safety and Health Administration (OSHA) has accepted its Whippany, New Jersey operations into the agency’s prestigious Voluntary Protection Programs (VPP) at the Star Level.

The VPP recognize employers and workers who have implemented effective safety and health management systems and maintain injury and illness rates below national Bureau of Labor Statistics averages for their respective industries. The highest award offered by the VPP, the Star Award is reserved for participants that consistently exceed OSHA standards, thereby making them models for their industry. There are approximately six million worksites in the United States under OSHA jurisdiction, and approximately 1,700 of those sites are certified in the VPP.

VPP participant sites experience 50 percent fewer lost workday injuries than would be expected of a similar facility with an “average” safety program and recognize participants for their dedication to safety excellence.

The Whippany location will remain OSHA Star certified for three years. At the end of the three-year period, STERIS must submit annual self-evaluations of the program and apply for recertification.

This is an outstanding distinction for STERIS and the Whippany location. Safety Excellence is a core value of STERIS and, through this award, the Whippany facility and its employees will join the other STERIS members of the VPP Family to serve as a model for our global operations.

The Whippany facility is the sixth location in the Applied Sterilization Technologies network, and the 13th STERIS facility overall to receive the VPP Star status.

STERIS whippany new jersey facility accepted into osha vpp programs at star level

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.
STERIS is pleased to announce our brooklyn park mn usa laboratory iso 17025 accreditation now incl
November 21, 2024
November 21, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory ISO 17025 accreditation now includes product and package testing services.